Uraoka Toshio, Saito Yutaka, Matsuda Takahisa, Sano Yasushi, Ikehara Hisatomo, Mashimo Yumi, Kikuchi Tsuyoshi, Saito Daizo, Saito Hiroshi
Division of Endoscopy, National Cancer Center Hospital, Tokyo, Japan.
J Gastroenterol Hepatol. 2008 Dec;23(12):1810-5. doi: 10.1111/j.1440-1746.2008.05635.x.
Flat and depressed colorectal neoplastic lesions can be difficult to identify using conventional colonoscopy techniques. Narrow-band imaging (NBI) provides unique views especially of mucosal vascular network and helps in visualization of neoplasia by improving contrast. The aim of this study was to assess the feasibility of using NBI for colorectal neoplasia screening.
Forty-seven consecutive patients, who underwent high definition colonoscopy (HDC) screening examinations revealing neoplastic lesions, were enrolled in our prospective study. No biopsies or resections were performed during the initial HDC, but patients in whom lesions were detected underwent further colonoscopies using NBI, with the results of the first examination blinded from the colonoscopist. They then received appropriate treatment. We compared diagnostic detection rates of neoplastic lesions for HDC and NBI procedures using total number of all identified neoplastic lesions as reference standard.
Altogether, 153 lesions were detected and analyzed in 43 patients. Mean diagnostic extubation times were not significantly different (P = 0.18), but the total number of lesions detected by NBI was higher (134 vs 116; P = 0.02). Based on macroscopic type, flat lesions were identified more often by NBI (P = 0.04). As for lesion size, only flat lesions < 5 mm were detected more frequently (P = 0.046). Lesions in the right colon were identified more often by NBI (P = 0.02), but NBI missed two flat lesions >or= 10 mm located there.
Narrow band imaging colonoscopy may represent a significant improvement in the detection of flat and diminutive lesions, but a future multi-center controlled trial should be conducted to fully evaluate efficacy for screening colonoscopies.
使用传统结肠镜检查技术难以识别扁平及凹陷性结直肠肿瘤性病变。窄带成像(NBI)能提供独特的视野,尤其是黏膜血管网络的视野,并通过改善对比度有助于肿瘤的可视化。本研究的目的是评估使用NBI进行结直肠肿瘤筛查的可行性。
47例连续接受高清结肠镜(HDC)筛查且发现肿瘤性病变的患者纳入我们的前瞻性研究。在初次HDC检查期间未进行活检或切除,但检测到病变的患者使用NBI接受进一步的结肠镜检查,且结肠镜检查医师不知道首次检查的结果。然后他们接受了适当的治疗。我们以所有识别出的肿瘤性病变总数作为参考标准,比较了HDC和NBI程序对肿瘤性病变的诊断检出率。
共43例患者检测并分析了153个病变。平均诊断退镜时间无显著差异(P = 0.18),但NBI检测到的病变总数更高(134个对116个;P = 0.02)。基于宏观类型,NBI更常识别出扁平病变(P = 0.04)。至于病变大小,仅<5 mm的扁平病变被更频繁地检测到(P = 0.046)。NBI更常识别出右半结肠的病变(P = 0.02),但NBI漏诊了位于该处的2个≥10 mm的扁平病变。
窄带成像结肠镜检查在扁平及微小病变的检测方面可能代表了一项重大改进,但未来应进行多中心对照试验以全面评估其在筛查结肠镜检查中的疗效。